Pat Connolly

Investor at Supermoon Capital | Former EVP, CMO, & Director at Williams-Sonoma, Inc.

📍 United States🔄 Updated September 2026💼 4 investments📅 6 years investing🗓 Last invested Mar 2021
VC🌍 United States
4
Total investments
1
Early stage
2
Mid stage
0
Late stage
6y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Mar 2021
Cerno Health is an early stage digital health company based in the SF Bay Area developing objective monitoring tools for early detection and longitudinal monitoring of chronic disorders.
Investor
May 2020
EnsoData uses Artificial Intelligence (AI) to unlock more rapid, accurate, and affordable diagnoses of the biggest threats to human health. Over the past eight years, EnsoData has pioneered the clinical use and adoption of artificial intelligence (AI) and machine learning (ML) technology in sleep medicine (and healthcare more broadly) to solve large-scale problems at the heart of diagnosis and treatment decision-making. EnsoData’s primary solution, EnsoSleep, was cleared by the FDA in 2017 to provide diagnostic analysis of in-lab sleep studies. EnsoSleep received expanded FDA clearance in 2021 to score and analyze home sleep studies, to add a viewing, editing, and reporting platform, and to record and output a total sleep time measurement. The latest EnsoData AI algorithm, EnsoSleep PPG, was cleared by the FDA in February of 2024. EnsoSleep PPG turns the widely available and wearable FDA-cleared pulse oximetry technology into a diagnostic tool for clinicians. This new clearance offers opportunities for clinicians to effectively reach patients by enabling AI-driven analysis using more accessible and cost-effective pulse oximeters. Ultimately, our suite of AI tools help clinicians reduce healthcare turnaround times, cut into patient backlogs, and ultimately, improve the patient care journey and health outcomes.
Investor
Apr 2020
Clair Labs is shaping the future of proactive healthcare with its novel contact-free vitals sensing technology. Based on breakthrough deep learning, computer vision and product design we build the holy grail of seamless monitoring. We envision wide adoption of our medical-grade technology in domains such as sleep disorder diagnosis, at-home pediatric care, chronic disease management, post-discharge patient monitoring and more.
Investor
Apr 2020
Endel is a technology that creates personalized sound environments to reduce stress, improve sleep, and boost productivity — all backed by neuroscience and the science of circadian rhythms. The soundscapes are algorithm-powered and designed to gently rise and fall in line with immediate internal and external conditions like location, time zone, weather, and heart rate. Endels technology is already presented as an ecosystem of products (iOS, macOS, Android apps, Alexa Skill, a standalone Apple Watch app and AppleTV) and also designed to be integrated into various hardware and platforms in mobility, hospitality, and workspaces. Major Lazers Jillionaire, Amazon Alexa Fund, and Avex are among some of the investors in Endel.
Experience · 5 entries
All (5)
Investments (4)
Founder (1)
2021
Investor
Mar 2021
Cerno Health is an early stage digital health company based in the SF Bay Area developing objective monitoring tools for early detection and longitudinal monitoring of chronic disorders.
2020
Investor
May 2020
EnsoData uses Artificial Intelligence (AI) to unlock more rapid, accurate, and affordable diagnoses of the biggest threats to human health. Over the past eight years, EnsoData has pioneered the clinical use and adoption of artificial intelligence (AI) and machine learning (ML) technology in sleep medicine (and healthcare more broadly) to solve large-scale problems at the heart of diagnosis and treatment decision-making. EnsoData’s primary solution, EnsoSleep, was cleared by the FDA in 2017 to provide diagnostic analysis of in-lab sleep studies. EnsoSleep received expanded FDA clearance in 2021 to score and analyze home sleep studies, to add a viewing, editing, and reporting platform, and to record and output a total sleep time measurement. The latest EnsoData AI algorithm, EnsoSleep PPG, was cleared by the FDA in February of 2024. EnsoSleep PPG turns the widely available and wearable FDA-cleared pulse oximetry technology into a diagnostic tool for clinicians. This new clearance offers opportunities for clinicians to effectively reach patients by enabling AI-driven analysis using more accessible and cost-effective pulse oximeters. Ultimately, our suite of AI tools help clinicians reduce healthcare turnaround times, cut into patient backlogs, and ultimately, improve the patient care journey and health outcomes.
Investor
Apr 2020
Clair Labs is shaping the future of proactive healthcare with its novel contact-free vitals sensing technology. Based on breakthrough deep learning, computer vision and product design we build the holy grail of seamless monitoring. We envision wide adoption of our medical-grade technology in domains such as sleep disorder diagnosis, at-home pediatric care, chronic disease management, post-discharge patient monitoring and more.
Investor
Apr 2020
Endel is a technology that creates personalized sound environments to reduce stress, improve sleep, and boost productivity — all backed by neuroscience and the science of circadian rhythms. The soundscapes are algorithm-powered and designed to gently rise and fall in line with immediate internal and external conditions like location, time zone, weather, and heart rate. Endels technology is already presented as an ecosystem of products (iOS, macOS, Android apps, Alexa Skill, a standalone Apple Watch app and AppleTV) and also designed to be integrated into various hardware and platforms in mobility, hospitality, and workspaces. Major Lazers Jillionaire, Amazon Alexa Fund, and Avex are among some of the investors in Endel.
2019
Co-Founder & Managing Partner
Oct 2019
Supermoon Capital is a venture capital firm helping visionary founders enhance our lives, organizations, and communities through healthy sleep.
Investment activity
2020–2021 · 4 investments
2020320211
Recent (last 2 years)Earlier